These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37261809)

  • 1. Difficulty in Assessing the Systemic Adverse Effects of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy.
    VanderBeek BL
    JAMA Ophthalmol; 2023 Jul; 141(7):666-667. PubMed ID: 37261809
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertensive cerebral hemorrhage with undetectable plasma vascular endothelial growth factor levels in a patient receiving intravitreal injection of aflibercept for bilateral diabetic macular edema: a case report.
    Yoshimoto M; Takeda N; Yoshimoto T; Matsumoto S
    J Med Case Rep; 2021 Jul; 15(1):403. PubMed ID: 34311786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in cardiac troponin T level after intravitreal anti-vascular endothelial growth factor treatment: Prospective pilot study.
    Rebeiz AG; Mahfoud Z; Abdul Fattah M; Saad A; Safar A; Bashshur ZF
    Eur J Ophthalmol; 2020 May; 30(3):563-569. PubMed ID: 30813779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review.
    Zehden JA; Mortensen XM; Reddy A; Zhang AY
    Curr Diab Rep; 2022 Oct; 22(10):525-536. PubMed ID: 36053385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Medication Use.
    Thulliez M; Angoulvant D; Pisella PJ; Bejan-Angoulvant T
    JAMA Ophthalmol; 2018 May; 136(5):557-566. PubMed ID: 29566105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor.
    Lin TY; Hsieh YT; Garg SJ; Chen LJ; Chen KJ; Wu WC; Lai CC; Hwang YS; Kang EY
    Ophthalmol Ther; 2023 Apr; 12(2):1127-1140. PubMed ID: 36729247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide.
    Morshedi RG; Ricca AM; Wirostko BM
    J Glaucoma; 2016 Mar; 25(3):291-300. PubMed ID: 25318578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies.
    Csaky K; Do DV
    Am J Ophthalmol; 2009 Nov; 148(5):647-56. PubMed ID: 19712924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center.
    Juncal VR; Francisconi CLM; Altomare F; Chow DR; Giavedoni LR; Muni RH; Berger AR; Wong DT
    Ophthalmologica; 2019; 242(1):1-7. PubMed ID: 30928983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WRINKLED VASCULARIZED RETINAL PIGMENT EPITHELIUM DETACHMENT PROGNOSIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lam D; Semoun O; Blanco-Garavito R; Jung C; Nguyen DT; Souied EH; Mimoun G
    Retina; 2018 Jun; 38(6):1100-1109. PubMed ID: 28520639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Adverse Events Among Patients With Diabetes Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Zafar S; Walder A; Virani S; Biggerstaff K; Orengo-Nania S; Chang J; Channa R
    JAMA Ophthalmol; 2023 Jul; 141(7):658-666. PubMed ID: 37261816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of subspecialty ophthalmic care: systemic complications from the intravitreal administration of agents that target the vascular endothelial growth factor pathway.
    Ramsey DJ; Haddock LJ; Young LH; Eliott D
    Semin Ophthalmol; 2014; 29(5-6):263-75. PubMed ID: 25325852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration.
    Dedania VS; Bakri SJ
    Curr Opin Ophthalmol; 2016 May; 27(3):224-43. PubMed ID: 26871657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and complications of intravitreal injections performed in an Asian population in Singapore.
    Xu Y; Tan CS
    Int Ophthalmol; 2017 Apr; 37(2):325-332. PubMed ID: 27236451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections.
    van der Reis MI; La Heij EC; De Jong-Hesse Y; Ringens PJ; Hendrikse F; Schouten JS
    Retina; 2011 Sep; 31(8):1449-69. PubMed ID: 21817960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report.
    Huang Y; Zhou R; Sun Z; Zheng Y; Lin B
    Int Breastfeed J; 2022 Mar; 17(1):25. PubMed ID: 35361227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.